首頁 > 市場調查報告書 > 醫療設備

體外診斷呼吸器

市場調查報告書

商品編碼

1623511

按測試類型、產品和服務、最終用戶、地區、範圍和預測劃分的全球呼吸診斷市場規模

Global Respiratory Diagnostics Market Size By Test Type, By Products And Services, By End User, By Geographic Scope And Forecast

出版日期: 2024年10月17日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

呼吸診斷市場規模及預測

2020年呼吸診斷市場規模為46.9億美元，預估2021年至2028年複合年增長率為6.3%，2028年達79.9億美元。

肺部相關疾病和感染發病率增加、老年人口增加以及技術發展等因素正在促使市場成長。另一方面，與報銷和醫療費用上升相關的風險可能會阻礙整體市場的成長。全球呼吸診斷市場報告提供了對市場的整體評估。它對關鍵細分市場、趨勢、市場推動因素、阻礙因素、競爭格局以及在市場中發揮關鍵作用的因素進行了全面分析。

呼吸診斷的全球市場定義

呼吸診斷是醫療領域和診斷中心最常使用的技術之一。市場成長的主要原因是年輕人生活方式的改變以及老年族群中與年齡相關的症狀和疾病。

全球呼吸診斷市場概況

肺部相關疾病和感染發病率增加、老年人口增加以及技術發展等因素正在促使市場成長。另一方面，醫療費用和醫療費用上漲相關的風險可能會阻礙整體市場的成長。吸菸、飲酒、久坐的生活方式和日常生活壓力的增加導致慢性阻塞性肺病和肺癌等嚴重呼吸道疾病的發生率增加。此外，呼吸診斷測試的多項技術創新，包括在慢性阻塞性肺病診斷和門診管理中使用人工智慧 (AI) 和物聯網 (IoT)，對市場成長產生了積極影響。

也存在一些阻礙市場成長的限制和課題。預計與 COPD 診斷和檢測相關的高價格、大量未診斷和未治療人群、嚴格的監管要求、缺乏認識以及報銷擔憂等因素限制了全球呼吸診斷市場的成長。

Factors such as increasing lung-related diseases and infections, the rise in the geriatric population, and technological developments are leading to growth in the market. On the other hand, risks associated with reimbursements and the rising healthcare cost might hinder the overall market growth. The Global Respiratory Diagnostics Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Respiratory Diagnostics Market Definition

Respiratory Diagnostics is one of the most used technologies in the medicinal sector and diagnostic centers. The reason for the market growth is mainly the lifestyle changes in the young population and age-related symptoms and diseases in the geriatric population.

Global Respiratory Diagnostics Market Overview

Factors such as increasing lung-related diseases and infections, the rise in the geriatric population and technological developments are leading to the growth in the market. On the other hand, risks associated with reimbursements and the rising healthcare cost might hinder the overall market growth. The growing number of smokers and consumption of alcohol, along with sedentary lifestyle habits and stressful routines, have resulted in increased incidences of COPD and other severe respiratory conditions, such as lung cancer. Moreover, several technological innovations in respiratory diagnostic testing, counting the use of Artificial Intelligence (AI) and the Internet of Things (IoT) for the diagnosis of COPD and outpatient management, are creating a positive impact on the market growth.

There are certain restraints and challenges faced which will hinder the market growth. Factors such as High price associated with COPD diagnosis and testing, a presence of a large population going undiagnosed and undertreated, Strict regulatory requirements, lack of awareness, and Reimbursement concerns are expected to restrain the growth of the global Respiratory Diagnostics Market.

Global Respiratory Diagnostics Market: Segmentation Analysis

Global Respiratory Diagnostics Market is segmented based on Test Type, Products and Services, End User, And Geography.

Respiratory Diagnostics Market, By Test Type

Mechanical Tests
OSA Diagnostic Tests
Imaging Tests
Molecular Diagnostic Tests
Others

Based on Test Type, the market is bifurcated into Mechanical Tests, OSA Diagnostic Tests, Imaging Tests, Molecular Diagnostic Tests, and Others. The OSA Diagnostic Tests segment is projected to account for the largest share of the market. The factors can be attributed to the quick turnaround time of these tests.

Respiratory Diagnostics Market, By Products And Services

Instruments and Devices
Assays and Reagents
Services and Software

Based on Products and Services, the market is bifurcated into Instruments and Devices, Assays and Reagents and Services & Software. The instruments and devices segment is anticipated to account for the largest share in the market. The factors can be attributed to the continuous requirement of diagnostic instruments and devices in point-of-care, laboratories, and home care.

Respiratory Diagnostics Market, By End User

Hospital/Clinical Laboratories
Reference Laboratories
Physician Offices
Other End Users

Based on End User, the market is bifurcated into Hospital/Clinical Laboratories, Reference Laboratories, Physician Offices and Other End Users. The Hospital/Clinical Laboratories segment is expected to account for the largest share of the global market due to most respiratory disease diagnostics are done in hospitals as they are complex and need technologically advanced products this factor is driving the market for Hospital/Clinical Laboratories.

Respiratory Diagnostics Market, By Geography

North America
Europe
Asia Pacific
Rest of the world
On the basis of Geography, the Global Respiratory Diagnostics Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The largest share in the market will be dominated by North America. The factors can be attributed to the growing prevalence of respiratory diseases and the increasing geriatric population in the region. Furthermore, the occurrence of an advanced healthcare system and robust distribution channels for respiratory diagnostic products are other factors supporting the growth of this market in North America.

Key Players

The "Global Respiratory Diagnostics Market" study report will provide a valuable insight with an emphasis on global market including some of the major players such as
Philips Healthcare, Becton, Dickinson & Company, Abbott Laboratories, Thermo Fisher Scientific Inc., Alere Inc., Bio-Rad Laboratories, Inc., Cosmed, Seegene Inc. and Sdi Diagnostic.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

Key Developments

Product Launches and Product Expansions
In June 2020, GE Healthcare launched the Thoracic Care Suite that has eight artificial intelligence (AI) algorithms that allow chest X-rays to detect abnormalities, including pneumonia detection, a symptom related to COVID-19. This new product launched by the company during the expansion of COVID-19 has enhanced the credibility of the company in the market.
On July 2020 BATM, a leading provider of real-time technologies for networking solutions and medical laboratory systems, has announced the launch of three new diagnostic kits to significantly advance the diagnosis of COVID-19 and other respiratory illnesses.
May 2020, Australian medical technology company, 4DMedical has received clearance from the US Food & Drug Administration to market its XV Technology, a patented four-dimensional lung imaging process that rapidly and automatically analyses any functional lung impairment from a single X-ray. 4DMedical's US operations are based in Woodland Hills, California.
Acquisition and Mergers
May 2020, SIME, a Clinical AI company specialising in rapid ICU diagnostics, announced it has entered into an exclusive agreement with an existing strategic investor to commercialise the company's point-of-care products and services in Latin America.

1 INTRODUCTION OF GLOBAL RESPIRATORY DIAGNOSTICS MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL RESPIRATORY DIAGNOSTICS MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE

5.1 Overview
5.2 Mechanical Tests
5.3 OSA Diagnostic Tests
5.4 Imaging Tests
5.5 Molecular Diagnostic Tests
5.6 Others

6 GLOBAL RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES

6.1 Overview
6.2 Instruments & Devices
6.3 Assays and Reagents
6.4 Services and Software

7 GLOBAL RESPIRATORY DIAGNOSTICS MARKET, BY END USER

7.1 Overview
7.2 Hospital/Clinical Laboratories
7.3 Reference Laboratories
7.4 Physician Offices
7.5 Other End Users

8 GLOBAL RESPIRATORY DIAGNOSTICS MARKET, BY GEOGRAPHY

8.1 Overview
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Rest of the World
- 8.5.1 Latin America
- 8.5.2 Middle East and Africa

9 GLOBAL RESPIRATORY DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE

9.1 Overview
9.2 Company Market ranking
9.3 Vendor Landscape
9.4 Key Development Strategies

10 COMPANY PROFILES

10.1 Philips Healthcare
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
10.2 Becton, Dickinson & Company
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
10.3 Abbott Laboratories
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
10.4 Thermo Fisher Scientific Inc.
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
10.5 Alere Inc.
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
10.6 Bio-Rad Laboratories, Inc.
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
10.7 Cosmed
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
10.8 Seegene Inc.
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments
10.9 Sdi Diagnostic
- 10.9.1 Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Outlook
- 10.9.4 Key Developments